Literature DB >> 26907757

Antimicrobial Properties and Cytotoxicity of Sulfated (1,3)-β-D-Glucan from the Mycelium of the Mushroom Ganoderma lucidum.

Wan Abd Al Qadr Imad Wan-Mohtar1, Louise Young2, Gráinne M Abbott2, Carol Clements2, Linda M Harvey1, Brian McNeil1.   

Abstract

Ganoderma lucidum BCCM 31549 has a long established role for its therapeutic activities. In this context, much interest has focused on the possible functions of the (1,3)-β-D-glucan (G) produced by these cultures in a stirred-tank bioreactor and extracted from their underutilized mycelium. In the existing study, we report on the systematic production of G, and its sulfated derivative (GS). The aim of this study was to investigate G and its GS from G. lucidum in terms of their antibacterial properties and cytotoxicity spectrum against human prostate cells (PN2TA) and human caucasian histiocytic lymphoma cells (U937). (1)H NMR for both G and GS compounds showed β-glycosidic linkages and structural similarities when compared with two standards (laminarin and fucoidan). The existence of characteristic absorptions at 1,170 and 867 cm(-1) in the FTIR (Fourier Transform Infrared Spectroscopy) for GS demonstrated the successful sulfation of G. Only GS exhibited antimicrobial activity against a varied range of test bacteria of relevance to foodstuffs and human health. Moreover, both G and GS did not show any cytotoxic effects on PN2TA cells, thus helping demonstrate the safety of these polymers. Moreover, GS showed 40% antiproliferation against cancerous U937 cells at the low concentration (60 μg/ ml) applied in this study compared with G (10%). Together, this demonstrates that sulfation clearly improved the solubility and therapeutic activities of G. The water-soluble GS demonstrates the potential multifunctional effects of these materials in foodstuffs.

Entities:  

Keywords:  (1,3)-β-D-glucan sulfate; Antimicrobial activity; Cytotoxicity; Ganoderma lucidum

Mesh:

Substances:

Year:  2016        PMID: 26907757     DOI: 10.4014/jmb.1510.10018

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  6 in total

Review 1.  Mushrooms: from nutrition to mycoremediation.

Authors:  Soumya Chatterjee; Mukul K Sarma; Utsab Deb; Georg Steinhauser; Clemens Walther; Dharmendra K Gupta
Journal:  Environ Sci Pollut Res Int       Date:  2017-08-03       Impact factor: 4.223

2.  Antifungal-demelanizing properties and RAW264.7 macrophages stimulation of glucan sulfate from the mycelium of the mushroom Ganoderma lucidum.

Authors:  Wan Abd Al Qadr Imad Wan-Mohtar; Christina Viegelmann; Anita Klaus; Sarina Abdul Halim Lim
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

3.  The morphology of Ganoderma lucidum mycelium in a repeated-batch fermentation for exopolysaccharide production.

Authors:  Wan Abd Al Qadr Imad Wan-Mohtar; Safuan Ab Kadir; Nazamid Saari
Journal:  Biotechnol Rep (Amst)       Date:  2016-05-17

4.  Use of Zebrafish Embryo Assay to Evaluate Toxicity and Safety of Bioreactor-Grown Exopolysaccharides and Endopolysaccharides from European Ganoderma applanatum Mycelium for Future Aquaculture Applications.

Authors:  Wan Abd Al Qadr Imad Wan-Mohtar; Zul Ilham; Adi Ainurzaman Jamaludin; Neil Rowan
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

5.  In vivo toxicity of bioreactor-grown biomass and exopolysaccharides from Malaysian tiger milk mushroom mycelium for potential future health applications.

Authors:  Wan Abd Al Qadr Imad Wan-Mohtar; Neil Rowan; Siti Rokhiyah Ahmad Usuldin; Zul Ilham; Adi Ainurzaman Jamaludin; Nur Raihan Abdullah
Journal:  Sci Rep       Date:  2021-11-29       Impact factor: 4.379

6.  Bioreactor-grown exo- and endo-β-glucan from Malaysian Ganoderma lucidum: An in vitro and in vivo study for potential antidiabetic treatment.

Authors:  Nur Raihan Abdullah; Mohd Hamzah Mohd Nasir; Nur Hafizah Azizan; Wan Abd Al Qadr Imad Wan-Mohtar; Faez Sharif
Journal:  Front Bioeng Biotechnol       Date:  2022-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.